L. He, “SGLT2 Inhibitor And GLP-1 Receptor Agonist in Type 2 Diabetes Mellitus Patients. Research on Their Cardiovascular Benefits”, HSET, vol. 74, pp. 1717–1722, Dec. 2023, doi: 10.54097/m9vm2798.